Table 1.
Study type | Setting | Subjects of study | Intervention | Outcomes | |
---|---|---|---|---|---|
Langley 2018 et al. [30] | ITS | United Kingdom | Antibiotics and inhaled corticosteroids | A cost-feedback approach to prescribers: the provision of information on the cost of drugs in electronic prescribing to clinicians in a hospital setting | Price outcomes (weekly expenditure; weekly cost per patient) |
Moodley 2019 et al. [22,23] | ITS | South Africa | Top-50 originator medicines dispensed in private sector by volume and corresponding generics | The Single-Exit-Price (SEP): mandatory disclosure of fixed medicine prices, that are composed of the weighted average of the sales price, the logistics fee and value-added taxes. All discounts and off-invoice rebates are removed. Applies to the private sector. The disclosed prices are made publicly available on the South African Medicine Price Registry website | Price outcome (relative change in medicine price) |
ITS=Interrupted time series.